SPOT-MAS is a non-invasive, multi-cancer early detection (MCED) test that detects tumor DNA (ctDNA) circulating in the blood. This test incorporates next-generation sequencing (NGS) and AI technologies to analyze the multiple features of ctDNA, enabling early detection for the most common and aggressive cancers from a single tube of blood.
